Manufacturer profile
Austell Pharmaceuticals (Pty) Ltd
Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.
What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.
5
Recorded actions
1
Countries
1
Authorities
0
Class I actions recorded
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-ZA-2026-83149863 | 24 Apr 2026 | ZA | Ciprofloxacin 250 MG Austell (Ciprofloxacin Hydrochloride) Austell Pharmaceuticals (Pty) Ltd | AEW014001 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-ZA-2024-90642188 | 21 Nov 2024 | ZA | ETORICOXIB 60 AUSTELL (ETORICOXIB 60,0 mg) Austell Pharmaceuticals | AGT4001 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-ZA-2024-68751182 | 10 Jan 2024 | ZA | Acenten 20/12,5 mg Tablets (Enalapril Maleate 20 mg and Hydrochlorothiazide 12.5mg) Austell Pharmaceuticals | JTU022001 · JTU022002 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-ZA-2023-69589526 | 24 May 2023 | ZA | Amuco 600 Effervescent Tablet (Acetylcysteine 600mg) Austell Pharmaceuticals | 42332 · 42333 · 42334 · 42386 · 42387 · 42388 · 42389 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-ZA-2022-51900791 | 29 Sept 2022 | ZA | Austell Azithromycin (Azithromycin 200 mg/5 ml powder for suspension) Austell Pharmaceuticals | MG22413 · MG22414 · MG22415 | Recall | Class III | Tier 1 · Regulator-published |
Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.
Names as published
This profile groups 2 spellings used by the issuing authorities: Austell Pharmaceuticals (Pty) Ltd; Austell Pharmaceuticals.
Company response
Drug Eye Africa has not yet invited a response from this company. That is our omission and not the company’s silence, and it is recorded here as one.
How this page is built
- Published regulator decisions only — no press reports, no allegations
- Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
- Every action links to its primary notice